Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Psoriasis lesions have fewer and smaller oil glands, which might affect the condition's development.

Finasteride reduces gambling symptoms in Parkinson's patients.

Saw palmetto extract is effective and safe for treating lower urinary tract symptoms, working as well as certain medications, and works even better in severe cases.

The new technique PÂTÉ improved the amount of scalp tissue removed in surgeries.

Effective sleep apnea treatment may reverse cognitive decline in Alzheimer's.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Improving prostate and urinary health can enhance sexual function and mental well-being in older men.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Herbal products for benign prostate hypertrophy need better quality checks to ensure safety and effectiveness.

SHH protein helps nerve regeneration in hypertensive rats.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

The submission argued that CPSO's referral policy undermines doctors' civil liberties and recommended changes to protect conscientious objections.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

Primary care doctors rarely use cancer prevention drugs due to concerns about side effects, costs, and effectiveness.

Using finasteride with TIP extends time off period for prostate cancer patients.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.